BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 143910)

  • 1. Topical clindamycin in acne vulgaris. Safety and stability.
    Algra RJ; Rosen T; Waisman M
    Arch Dermatol; 1977 Oct; 113(10):1390-1. PubMed ID: 143910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical clindamycin formulations for the treatment of acne vulgaris. An evaluation.
    McKenzie MW; Beck DC; Popovich NG
    Arch Dermatol; 1981 Oct; 117(10):630-4. PubMed ID: 6456699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
    Gold MH; Rao J; Goldman MP; Bridges TM; Bradshaw VL; Boring MM; Guider AN
    J Drugs Dermatol; 2005; 4(1):64-70. PubMed ID: 15696987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
    Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
    Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
    J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical treatment of acne vulgaris with clindamycin].
    Mobacken H; Hersle K
    Lakartidningen; 1985 Oct; 82(42):3595-7. PubMed ID: 2932616
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical clindamycin therapy for acne vulgaris. A cooperative clinical study.
    Becker LE; Bergstresser PR; Whiting DA; Clendenning WE; Dobson RL; Jordan WP; Abell E; LeZotte LA; Pochi PE; Shupack JL; Sigafoes RB; Stoughton RB; Voorhees JJ
    Arch Dermatol; 1981 Aug; 117(8):482-5. PubMed ID: 6455095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris.
    Alirezaï M; Gerlach B; Horvath A; Forsea D; Briantais P; Guyomar M
    Eur J Dermatol; 2005; 15(4):274-8. PubMed ID: 16048758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of topically applied clindamycin for acne.
    Fisher AA
    Cutis; 1979 Apr; 23(4):406, 416-8, 522. PubMed ID: 154993
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical antibiotics for acne vulgaris. Current usage.
    Stoughton RB
    Arch Dermatol; 1979 Apr; 115(4):486-9. PubMed ID: 155425
    [No Abstract]   [Full Text] [Related]  

  • 11. A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
    Chassard D; Kanis R; Namour F; Evene E; Ntssikoussalabongui B; Schmitz V
    J Dermatolog Treat; 2006; 17(3):154-7. PubMed ID: 16854755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical clindamycin in the control of acne vulgaris.
    Stoughton RB; Resh W
    Cutis; 1976 Mar; 17(3):551-4. PubMed ID: 138549
    [No Abstract]   [Full Text] [Related]  

  • 13. Topically administered clindamycin in the treatment of acne vulgaris and other dermatologic disorders.
    Rosen T; Waisman M
    Pharmacotherapy; 1981; 1(3):201-5. PubMed ID: 6242711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
    Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
    Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical clindamycin in acne: a preliminary study.
    Panzer JD; Panzer JJ
    Cutis; 1979 Jul; 24(1):118-9. PubMed ID: 157850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of liposome encapsulated clindamycin for treatment of acne vulgaris.
    Honzak L; Sentjurc M
    Pflugers Arch; 2000; 440(5 Suppl):R44-5. PubMed ID: 11005607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical clindamycin versus oral tetracycline and placebo in acne vulgaris.
    Braathen LR
    Scand J Infect Dis Suppl; 1984; 43():71-5. PubMed ID: 6242073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin.
    Tschen E; Jones T
    J Drugs Dermatol; 2002 Sep; 1(2):153-7. PubMed ID: 12847739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.